SynthesisBMC psychiatry2026
Gene expression meta-analysis in the prefrontal cortex: unraveling biological underpinnings of suicidal risk.
Synthesis in BMC psychiatry, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundSuicide is a complex public health challenge. Although psychosocial factors are important, molecular dysregulations in the prefrontal cortex (PFC) have been implicated in suicidal behavior.
methodsSix post-mortem PFC transcriptomic datasets from Gene Expression Omnibus (GEO) were analyzed to investigate the molecular basis of suicide, a major public health problem whose underlying mechanisms remain incompletely understood. After harmonizing microarray and sequencing data from 248 individuals younger than 60 years, both global and diagnosis-stratified meta-analyses were performed, focusing on major depressive disorder (MDD) and bipolar disorder (BPD).
resultsIn the overall comparison between suicide cases and controls, 10 nominally differentially expressed genes were identified, although none remained significant after multiple-testing correction. In the MDD-stratified analysis, four genes survived false discovery rate (FDR) correction (HRH3, PDE2A, NET1, and RHBDF2) and were associated with stress-related pathways, cyclic nucleotide signaling, and synaptic organization. No significant genes were identified in the bipolar disorder subgroup.
conclusionThese findings suggest that suicide-related transcriptomic alterations in the PFC are not uniform or clearly transdiagnostic, but may be partly shaped by the underlying psychiatric diagnosis, with a more clearly detectable signal in cases with MDD. This study provides a harmonized, bias-aware framework for integrating heterogeneous post-mortem transcriptomic datasets; however, the results should be interpreted as hypothesis-generating candidate signals rather than as definitive biomarkers, and require independent replication and functional validation.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.